Linscott Walt Addison 4
4 · Intec Pharma Ltd. · Filed Sep 16, 2019
Insider Transaction Report
Form 4
Linscott Walt Addison
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2019-09-13+200,000→ 200,000 totalExercise: $0.90Exp: 2026-09-13→ Ordinary Shares (200,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on September 13, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through September 13, 2022.